Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Mood and anxiety disorders are among the major causes of disability worldwide. Despite clear need for better therapies, efforts to develop novel drugs have been relatively unsuccessful. One major reason is lack of translation into neuropsychopharmacology of the impressive recent array of knowledge accrued by clinical and preclinical researches on the brain. Here focus is on epigenetics mechanisms, including microRNAs, which seem particularly promising for the identification of new targets for alternative pharmacological approaches. AREAS COVERED: First, the current knowledge about epigenetic mechanisms, including DNA methylation, posttranslational modification of histone proteins, focusing on histone methylation and acetylation, and posttranscriptional modulation of gene expression by microRNAs is described. Then evidence showing involvement of epigenetics and microRNAs in the pathophysiology of mood and anxiety disorders as well as evidence showing that some of the currently employed antidepressants and mood stabilizers also affect epigenetic and microRNA mechanisms are reviewed. Finally current evidence and novel approaches in favor of drugs regulating epigenetic and microRNA mechanisms as potential therapeutics for these disorders are discussed. EXPERT OPINION: Although still in its infancy, research investigating the effects of pharmacological modulation of epigenetic and microRNA mechanisms in neuropsychiatric disorders continues to provide encouraging findings, suggesting new avenues for treatment of mood and anxiety disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011
Gene silencing by microRNAs: contributions of translational repression and mRNA decay
Huntzinger, E., & Izaurralde, E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2936 · Cited by 2,339
A brain-specific microRNA regulates dendritic spine development
Schratt, G. M., Tuebing, F., Nigh, E. A., Kane, C. G., Sabatini, M. E., Kiebler, M., & Greenberg, M. E. (2006) · Nature · doi:10.1038/nature04367 · Cited by 1,786
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action
Tsankova, N. M., Berton, O., Renthal, W., Kumar, A., Neve, R. L., & Nestler, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1659 · Cited by 1,780
Cost of disorders of the brain in Europe 2010
Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.08.008 · Cited by 1,723
HDAC2 negatively regulates memory formation and synaptic plasticity
Guan, J.-S., Haggarty, S. J., Giacometti, E., Dannenberg, J.-H., Joseph, N., Gao, J., Nieland, T. J. F., Zhou, Y., Wang, X., Mazitschek, R., et al. (2009) · Nature · doi:10.1038/nature07925 · Cited by 1,644 · cited 1×
“, stress), and pathophysiology of psychiatric disorders, including MD [15-18].”
BackgroundBASKERVILLE, S., & BARTEL, D. P. (2005) · RNA · doi:10.1261/rna.7240905 · Cited by 1,508
Epigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400 · cited 4×
“4 Epigenetics in mood and anxiety disorders Numerous lines of evidence have implicated epigenetic mechanisms in MD and AD [14,16].”
BackgroundInfluentialLasting epigenetic influence of early-life adversity on the BDNF gene
Roth, T. L., Lubin, F. D., Funk, A. J., & Sweatt, J. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.028 · Cited by 1,273 · cited 3×
“, coding exon 9) mRNA levels and increased methylation at BDNF-4 and BDNF-9 exons in prefrontal cortex (PFC) of adult rats exposed to early life maltreatment [34].”
BackgroundMethodDynamic DNA methylation programs persistent adverse effects of early-life stress
Murgatroyd, C., Patchev, A. V., Wu, Y., Micale, V., Bockmühl, Y., Fischer, D., Holsboer, F., Wotjak, C. T., Almeida, O. F. X., & Spengler, D. (2009) · Nature Neuroscience · doi:10.1038/nn.2436 · Cited by 1,162 · cited 3×
“This hypomethylation was accompanied by increased secretion of corticosterone and increased immobility in the forced swim test (FST) [33].”
BackgroundReversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase
Kubicek, S., O'Sullivan, R. J., August, E. M., Hickey, E. R., Zhang, Q., Teodoro, M. L., Rea, S., Mechtler, K., Kowalski, J. A., Homon, C. A., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.017 · Cited by 859
Weaver, I. C. G., Meaney, M. J., & Szyf, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507526103 · Cited by 771 · cited 2×
“In adulthood, the progeny of poorer maternal caregiver dams display an anxious phenotype, higher corticosterone in response to stress, higher DNA methylation at the splice variant 17 of the glucocorticoid receptor (GR) promoter in hippocampus, lower histone H3 acetylation at lysine 9 (H3K9ac), reduced binding of the T…”
BackgroundSchratt, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2763 · Cited by 748
Research and treatment approaches to depression
Wong, M.-L., & Licinio, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35072566 · Cited by 656
Antidepressant Actions of Histone Deacetylase Inhibitors
Covington, H. E., Maze, I., LaPlant, Q. C., Vialou, V. F., Ohnishi, Y. N., Berton, O., Fass, D. M., Renthal, W., Rush, A. J., Wu, E. Y., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1758-09.2009 · Cited by 624 · cited 3×
“SAHA Class I and class II HDAC inhibitor Histone acetylation [55] HMT/HDM inhibitors DZNep EZH2 HMT inhibitor H3K27 methylation [22,58] BIX-01294 G9a HMT inhibitor H3K9 methylation [122] E67-2 JHDM1D HDM inhibitor H3K9 demethylation [59] SL11144 LSD1 HDM inhibitor H3K4 demethylation [22]”
BackgroundPerkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., Parker, J. S., Jin, J., & Hammond, S. M. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r27 · Cited by 574 · cited 2×
“were the first to describe an altered expression profile of miRNAs in PFC of schizophrenic and schizoaffective individuals [92].”
BackgroundResultBredy, T. W., Wu, H., Crego, C., Zellhoefer, J., Sun, Y. E., & Barad, M. (2007) · Learning & Memory · doi:10.1101/lm.500907 · Cited by 548 · cited 1×
“This was accompanied by increased H4 acetylation around BDNF-1 and BDNF-4 promoters, and increased expression of BDNF-4 mRNA in mouse PFC subjected to partial extinction training [45].”
BackgroundAntidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse
Schroeder, F. A., Lin, C. L., Crusio, W. E., & Akbarian, S. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.036 · Cited by 541 · cited 4×
“A study showed that both systemic and intra-hippocampal administration of 5-azaC and 5-azaD have antidepressant-like effect in the FST and tail suspension test (TST), widely used to assay compounds with antidepressant activity.”
MethodResultInfluentialMiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants
Baudry, A., Mouillet-Richard, S., Schneider, B., Launay, J.-M., & Kellermann, O. (2010) · Science · doi:10.1126/science.1193692 · Cited by 480
Epigenetics of the depressed brain: role of histone acetylation and methylation
Sun, H., Kennedy, P. J., & Nestler, E. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.73 · Cited by 413 · cited 10×
“In addition, transgenic mice overexpressing SET Domain Bifurcated 1 (SETDB1) (another H3K9-specific HMT) in forebrain areas showed antidepressant-like behavior [14,18].”
BackgroundInfluentialSmalheiser, N. R., Lugli, G., Rizavi, H. S., Torvik, V. I., Turecki, G., & Dwivedi, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033201 · Cited by 324
Kim, A. H., Reimers, M., Maher, B., Williamson, V., McMichael, O., McClay, J. L., van den Oord, E. J. C. G., Riley, B. P., Kendler, K. S., & Vladimirov, V. I. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.002 · Cited by 298 · cited 2×
“Target analysis for four validated miRNAs yielded prediction of 2,666 genes; several of them were from networks related to nervous system function and disease [93].”
BackgroundResultMoreau, M. P., Bruse, S. E., David-Rus, R., Buyske, S., & Brzustowicz, L. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.039 · Cited by 279
MicroRNAs shape the neuronal landscape
McNeill, E., & Van Vactor, D. (2012) · Neuron · doi:10.1016/j.neuron.2012.07.005 · Cited by 274 · cited 1×
“miR-SP can be placed downstream of promoters, thus conferring spatiotemporal control of miR-SP deployment, and recently miR-SP transgenics have been tested in mice CNS, where their ability to simultaneously inhibit miRNA family members has been shown [113].”
BackgroundThe epigenetics of social adversity in early life: Implications for mental health outcomes
McGowan, P. O., & Szyf, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.026 · Cited by 272
microRNA as Repressors of Stress-Induced Anxiety: The Case of Amygdalar miR-34
Haramati, S., Navon, I., Issler, O., Ezra-Nevo, G., Gil, S., Zwang, R., Hornstein, E., & Chen, A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1673-11.2011 · Cited by 252
Blood microRNA changes in depressed patients during antidepressant treatment
Bocchio-Chiavetto, L., Maffioletti, E., Bettinsoli, P., Giovannini, C., Bignotti, S., Tardito, D., Corrada, D., Milanesi, L., & Gennarelli, M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.06.013 · Cited by 238 · cited 2×
“miRNA targets prediction, and functional annotation analysis showed a significant enrichment in several pathways associated with neuronal function (such as neuroactive ligand-receptor interaction, axon guidance, long-term potentiation (LTP) and depression), supporting the hypothesis that these miRNAs may be involved i…”
BackgroundSelf-citationErnst, C., Deleva, V., Deng, X., Sequeira, A., Pomarenski, A., Klempan, T., Ernst, N., Quirion, R., Gratton, A., Szyf, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archpsyc.66.1.22 · Cited by 235 · cited 2×
“Indeed, as discussed above, several reports involve H3K27me3 in the neurobiology of psychiatric disorders [35,36,38].”
BackgroundGeneral Principals of miRNA Biogenesis and Regulation in the Brain
O'Carroll, D., & Schaefer, A. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.87 · Cited by 205 · cited 4×
“Individual miRNAs have the potential to target hundreds of different mRNAs, and a single mRNA could be modulated by several different miRNAs, thus implying a coordinate and fine-tuned expression of proteins in a cell and even in particular cell compartments [68,70].”
BackgroundInfluentialUchida, S., Nishida, A., Hara, K., Kamemoto, T., Suetsugi, M., Fujimoto, M., Watanuki, T., Wakabayashi, Y., Otsuki, K., McEwen, B. S., et al. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06218.x · Cited by 203 · cited 1×
“Briefly, an increase in miR-18a levels, which targets the GR, was found in the hypothalamus of a stress-sensitive rat strain [87].”
BackgroundSaus, E., Soria, V., Escaramís, G., Vivarelli, F., Crespo, J. M., Kagerbauer, B., Menchón, J. M., Urretavizcaya, M., Gratacòs, M., & Estivill, X. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq316 · Cited by 163
Yamawaki, Y., Fuchikami, M., Morinobu, S., Segawa, M., Matsumoto, T., & Yamawaki, S. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.585663 · Cited by 117 · cited 5×
“DNMT inhibitors AzaC Cytidine analog DNA methylation [48] AzaD Cytidine analog DNA methylation [48] Zebularine Cytidine analog DNA methylation [34] RG108 Non-nucleoside inhibitor DNA methylation [48] HDAC inhibitors SB Class I and class II HDAC inhibitor Histone acetylation; Histone methylation [35,52-54,120]”
BackgroundMethodInfluentialEffects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety
Gundersen, B. B., & Blendy, J. A. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.04.008 · Cited by 112
Xu, Y., Liu, H., Li, F., Sun, N., Ren, Y., Liu, Z., Cao, X., Wang, Y., Liu, P., & Zhang, K. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.05.019 · Cited by 99
Ernst, C., Chen, E. S., & Turecki, G. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.35 · Cited by 98 · cited 1×
“T1) (a BDNF receptor isoform mostly expressed in astrocytes) was significantly lower with respect to controls, and that this downregulation was associated with methylation at specific CpG dinucleotides near coding regionof the gene andwith increasedH3K27methylation [38,39].”
BackgroundCruceanu, C., Alda, M., Nagy, C., Freemantle, E., Rouleau, G. A., & Turecki, G. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000363 · Cited by 93
Current status and future prospects for epigenetic psychopharmacology
Boks, M. P., de Jong, N. M., Kas, M. J. H., Vinkers, C. H., Fernandes, C., Kahn, R. S., Mill, J., & Ophoff, R. A. (2012) · Epigenetics · doi:10.4161/epi.7.1.18688 · Cited by 89 · cited 8×
“2 Histone deacetylase inhibitors HDACi can be divided into different chemical classes, the main ones being the short-chain fatty acids (such as valproic acid and butyrates), hydroximates (such as suberoylanilide hydroxamic acid [SAHA] and trichostatin A) and benzamides (such as MS-275) [29].”
BackgroundInfluentialGenetic Variations in MicroRNA Processing Genes Are Associated with Susceptibility in Depression
He, Y., Zhou, Y., Xi, Q., Cui, H., Luo, T., Song, H., Nie, X., Wang, L., & Ying, B. (2012) · DNA and Cell Biology · doi:10.1089/dna.2012.1660 · Cited by 52 · cited 1×
“Finally, a recent work identified association between specific variants in DGCR8 and Ago1 and depression in a case-control study [98].”
Background
Cited by
The Emerging Field of Neuroepigenetics
Sweatt, J. D. (2013) · Neuron · doi:10.1016/j.neuron.2013.10.023 · Cited by 324
“A wide variety of non-coding RNAs have either been shown to be or hypothesized to be involved in regulating cell function in the nervous system, including: piRNAs, microRNAs, small interfering RNAs (siRNAs), and small nuclear RNAs (snRNAs) (Sun et al 2013; Tardito et al 2013).”
Peripheral whole blood microRNA alterations in major depression and bipolar disorder
Maffioletti, E., Cattaneo, A., Rosso, G., Maina, G., Maj, C., Gennarelli, M., Tardito, D., & Bocchio-Chiavetto, L. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.021 · Cited by 181
Self-citationEmerging role of microRNAs in major depressive disorder: diagnosis and therapeutic implications
Dwivedi, Y. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.1/ydwivedi · Cited by 169
“Recent evidence suggests that miRNA biogenesis can be regulated at the epigenetic level.(48) For example, inhibitors of DNA methylation and histone deacetylases can affect expression of several miRNAs.”
BackgroundMamdani, M., Williamson, V., McMichael, G. O., Blevins, T., Aliev, F., Adkins, A., Hack, L., Bigdeli, T., D. van der Vaart, A., Web, B. T., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0137671 · Cited by 73
Thinking small: towards microRNA-based therapeutics for anxiety disorders
Scott, K. A., Hoban, A. E., Clarke, G., Moloney, G. M., Dinan, T. G., & Cryan, J. F. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.997873 · Cited by 52
“In addition to genetic and environmental factors, it is clear that epigenetics, changes in gene expression that are influenced by the environment and that do not change the actual sequence of the DNA, are also involved in susceptibility and resilience to pathological conditions [23,24].”
Background
Metadata
- Authors
- Tardito, D., Mallei, A., & Popoli, M.
- Venue
- Expert Opinion on Investigational Drugs
- Publisher
- Informa UK Limited
- Published
- 2012-12-19
- Volume
- 22
- Issue
- 2
- Pages
- 217-233
- ISSN
- 1354-3784 (ISSN-L)
- 1744-7658
- OpenAlex
- W2072315340
- Cited by
- 35
- References
- 38
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.